Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Bicycle Therapeutics (BCYC) Accumulated Depreciation & Amortization (2018 - 2025)

Bicycle Therapeutics' Accumulated Depreciation & Amortization history spans 8 years, with the latest figure at $6.4 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization fell 11.11% year-over-year to $6.4 million; the TTM value through Dec 2025 reached $6.4 million, down 11.11%, while the annual FY2025 figure was $6.4 million, 11.11% down from the prior year.
  • Accumulated Depreciation & Amortization reached $6.4 million in Q4 2025 per BCYC's latest filing, up from $1.8 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $10.4 million in Q2 2023 to a low of $1.6 million in Q2 2024.
  • Average Accumulated Depreciation & Amortization over 5 years is $4.6 million, with a median of $4.8 million recorded in 2021.
  • Peak YoY movement for Accumulated Depreciation & Amortization: skyrocketed 101.58% in 2023, then tumbled 84.68% in 2024.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $4.8 million in 2021, then dropped by 22.92% to $3.7 million in 2022, then soared by 75.68% to $6.5 million in 2023, then grew by 10.77% to $7.2 million in 2024, then fell by 11.11% to $6.4 million in 2025.
  • Per Business Quant, the three most recent readings for BCYC's Accumulated Depreciation & Amortization are $6.4 million (Q4 2025), $1.8 million (Q3 2025), and $1.7 million (Q2 2025).